// App-Quantinova.ai

9090 : Biomarker-enriched efficacy of cetuximab-based therapy: Squamous subset analysis from S0819, a phase III trial of chemotherapy with or without cetuximab in advanced NSCLC.

Researchers

Presenter

  • Fred R. Hirsch

Principal Investigators

  • Mary Weber Redman

  • Roy S. Herbst

  • Edward S. Kim

  • Thomas John Semrad

  • Lyudmila Bazhenova

  • Gregory A. Masters

  • Kurt R. Oettel

  • Perry Guaglianone

  • Christopher M. Reynolds

  • Anand B. Karnad

  • Susanne M. Arnold

  • Marileila Varella-Garcia

  • James Moon

  • Philip C. Mack

  • Charles David Blanke

  • Karen Kelly

  • David R. Gandara

Medical Centers

  • Univ of Colorado Cancer Ctr, Denver, CO

  • Fred Hutchinson Cancer Resaerch Center, Seattle, WA

  • Yale University School of Medicine and Yale Cancer Center, New Haven, CT

  • Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC

  • University of California, San Francisco, CA

  • Center for Personalized Cancer Therapy and Division of Hematology and Oncology, UCSD Moores Cancer Center, La Jolla, San Diego, CA

  • Helen F Graham Cancer Ctr, Newark, DE

  • Gundersen Lutheran Hospital/Clinic, La Crosse, WI

  • Cancer Care Spec of Central Illinois, Decatur, IL

  • IHA Hem Onc Consult, Ann Arbor, MI

  • University of Texas Health Science Center San Antonio, San Antonio, TX

  • Markey Cancer Center, University of Kentucky, Lexington, KY

  • University of Colorado Denver School of Medicine, Aurora, CO

  • Fred Hutchinson Cancer Resaerch Center, Seattle, WA

  • UC Davis Comprehensive Cancer Center, Sacramento, CA

  • Oregon Health and Science University, Portland, OR

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

Biomarkers

  • Epidermal growth factor receptor

Drug/Treatment

  • Erbitux

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • NCT00946712

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved